Provided by Tiger Trade Technology Pte. Ltd.

Tandem Diabetes Care

15.68
-0.1650-1.04%
Post-market: 15.67-0.0050-0.03%16:43 EDT
Volume:2.90M
Turnover:44.96M
Market Cap:1.09B
PE:-16.90
High:15.77
Open:15.57
Low:15.13
Close:15.84
52wk High:29.65
52wk Low:12.26
Shares:69.58M
Float Shares:63.59M
Volume Ratio:1.43
T/O Rate:4.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9274
EPS(LYR):-3.0424
ROE:-48.03%
ROA:-2.65%
PB:8.36
PE(LYR):-5.15

Loading ...

Tandem Diabetes Care Price Target Announced at $18.00/Share by Barclays

Dow Jones
·
Oct 07

Tandem Diabetes initiated with an Equal Weight at Barclays

TIPRANKS
·
Oct 07

Tandem Diabetes Care (TNDM) Receives a Buy from RBC Capital

TIPRANKS
·
Oct 03

Tandem Diabetes Care Schedules Third-Quarter Results Conference Call

Reuters
·
Oct 02

Tandem Diabetes Care, Inc. : Citigroup Cuts Target Price to $20 from $24

THOMSON REUTERS
·
Sep 30

Tandem Diabetes Launches Mobi Insulin Delivery System in 12 International Markets

Reuters
·
Sep 28

Tandem Diabetes Care is Maintained at Buy by Truist Securities

Dow Jones
·
Sep 25

Truist Lowers Price Target on Tandem Diabetes Care to $28 From $31, Keeps Buy Rating

MT Newswires Live
·
Sep 24

Tandem Diabetes initiated with an Outperform at William Blair

TIPRANKS
·
Aug 21

How Tandem’s Q2 Loss and Pharmacy Pivot Will Impact Tandem Diabetes Care (TNDM) Investors

Simply Wall St.
·
Aug 20

Tandem Diabetes price target raised to $24 from $21 at Citi

TIPRANKS
·
Aug 17

Citi Sticks to Its Hold Rating for Tandem Diabetes Care (TNDM)

TIPRANKS
·
Aug 14

Tandem Diabetes Care: Buy Rating Reaffirmed on Transformation Momentum and Innovation Catalysts; $40 Price Target Maintained

TIPRANKS
·
Aug 12

Tandem Diabetes Care Price Target Raised to $21.00/Share from $17.00 by Citigroup

Dow Jones
·
Aug 08

Tandem Diabetes Care's Underlying Q2 Trends Better Than Headline Suggests, RBC Says

MT Newswires Live
·
Aug 08

Stifel Nicolaus Reaffirms Their Hold Rating on Tandem Diabetes Care (TNDM)

TIPRANKS
·
Aug 08

RBC Adjusts PT on Tandem Diabetes Care to $26 From $30, Maintains Outperform Rating

MT Newswires Live
·
Aug 07

Tandem Diabetes price target raised to $40 from $35 at Canaccord

TIPRANKS
·
Aug 07

Tandem Diabetes Care, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Tandem Diabetes Care Q2 EPS $(0.31) Beats $(0.32) Estimate, Sales $254.560M Miss $254.978M Estimate

Benzinga Earnings
·
Aug 07